Clinical trial
Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients
NCT06029634 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients
- Lead sponsor
- Changhai Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2020
- Completion date
- August 20, 2023
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hbv infection, drug withdrawal